Using propensity matching, the researchers compared 2,894 patients taking a GLP-1 receptor agonist at baseline with 2,894 patients not taking one at baseline
When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife backlash
In this regard, findings reported by Sauv et al.33 show a clear trend to a greater activation of survival pathways in the myocardium of diabetic animals treated with liraglutide as compared to sitagliptin
This position is supported by the NICE Guideline and at the end of 2025 we launched our freely accessible Pernicious Anaemia and B12 Deficiency education programme to the NHS community
Iyer KS, McCann SM
Timing your supplements can make a big difference if you are trying to optimize your performance, aesthetics, and recovery